• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长潜伏期间日疟原虫的兴衰。

The rise and fall of long-latency Plasmodium vivax.

机构信息

Mahidol Oxford Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

出版信息

Trans R Soc Trop Med Hyg. 2019 Apr 1;113(4):163-168. doi: 10.1093/trstmh/trz002.

DOI:10.1093/trstmh/trz002
PMID:30809676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6432802/
Abstract

Until World War II the only clinical phenotype of Plasmodium vivax generally recognised in medicine was one associated with either a long (8-9 months) incubation period or a similarly long interval between initial illness and the first relapse. Long-latency P. vivax 'strains' were the first in which relapse, drug resistance and pre-erythrocytic development were described. They were the infections in which primaquine radical cure dosing was developed. A long-latency 'strain' was the first to be fully sequenced. Although long-latency P. vivax is still present in some parts of Asia, North Africa and the Americas, in recent years it has been largely forgotten.

摘要

直到第二次世界大战,医学界普遍认可的间日疟原虫唯一临床表型是与较长潜伏期(8-9 个月)或初始发病和首次复发之间类似的较长间隔相关的表型。长潜伏期间日疟原虫“株”是首次描述复发、耐药性和红细胞前期发育的疟原虫。它们是开发伯氨喹根治剂量的感染。长潜伏期“株”是第一个被完全测序的疟原虫。尽管长潜伏期间日疟原虫在亚洲、北非和美洲的某些地区仍然存在,但近年来已被人们淡忘。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552a/6432802/b876da49ed69/trz002f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552a/6432802/b876da49ed69/trz002f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552a/6432802/b876da49ed69/trz002f01.jpg

相似文献

1
The rise and fall of long-latency Plasmodium vivax.长潜伏期间日疟原虫的兴衰。
Trans R Soc Trop Med Hyg. 2019 Apr 1;113(4):163-168. doi: 10.1093/trstmh/trz002.
2
Management of relapsing Plasmodium vivax malaria.复发性间日疟的管理
Expert Rev Anti Infect Ther. 2016 Oct;14(10):885-900. doi: 10.1080/14787210.2016.1220304. Epub 2016 Aug 31.
3
[Role of primaquine in malaria control and elimination in French-speaking Africa].[伯氨喹在非洲法语区疟疾控制与消除中的作用]
Bull Soc Pathol Exot. 2017 Aug;110(3):198-206. doi: 10.1007/s13149-017-0556-z. Epub 2017 Apr 17.
4
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.他非诺喹及其在间日疟治疗和预防复发中的潜力:迄今的证据
Drug Des Devel Ther. 2016 Jul 26;10:2387-99. doi: 10.2147/DDDT.S61443. eCollection 2016.
5
Plasmodium vivax in the Era of the Shrinking P. falciparum Map.《在恶性疟原虫地图不断缩小的时代中的间日疟原虫》
Trends Parasitol. 2020 Jun;36(6):560-570. doi: 10.1016/j.pt.2020.03.009. Epub 2020 Apr 22.
6
Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.美国陆军部队中的间日疟原虫感染:在索马里进行的研究中,伯氨喹预防复发失败。
Am J Trop Med Hyg. 1997 Feb;56(2):231-4. doi: 10.4269/ajtmh.1997.56.231.
7
Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.日本旅行者间日疟原虫和卵形疟原虫根治的最佳磷酸萘酚喹用药方案:回顾性分析。
Travel Med Infect Dis. 2015 May-Jun;13(3):235-40. doi: 10.1016/j.tmaid.2014.11.005. Epub 2014 Nov 20.
8
Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.估算替法诺喹在巴西控制和消除间日疟原虫的影响:一项建模研究。
PLoS Med. 2021 Apr 23;18(4):e1003535. doi: 10.1371/journal.pmed.1003535. eCollection 2021 Apr.
9
Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.因剂量依赖性伯氨喹耐药导致的间日疟原体重症复发:一例报告
Scand J Infect Dis. 2014 Jan;46(1):63-5. doi: 10.3109/00365548.2013.822093. Epub 2013 Aug 19.
10
Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.对恶性疟原虫的基因分型显示,加尔各答既有短期潜伏期又有长期潜伏期的复发模式。
PLoS One. 2012;7(7):e39645. doi: 10.1371/journal.pone.0039645. Epub 2012 Jul 13.

引用本文的文献

1
Does mass chloroquine treatment have any role in the elimination of Plasmodium vivax ?大规模氯喹治疗在间日疟原虫消除过程中起作用吗?
Malar J. 2025 May 26;24(1):166. doi: 10.1186/s12936-025-05399-2.
2
Tracing the origins of Plasmodium vivax resurgence after malaria elimination on Aneityum Island in Vanuatu.探寻瓦努阿图阿内蒂乌姆岛疟疾消除后间日疟原虫再度流行的起源。
Commun Med (Lond). 2024 May 18;4(1):91. doi: 10.1038/s43856-024-00524-9.
3
Profile and determinants of delayed care-seeking and diagnosis among patients with imported malaria: a retrospective study in China, 2014-2021.

本文引用的文献

1
On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR.关于间日疟原虫疟疾的流行病学:过去和现在,特别提到前苏联。
Malar J. 2018 Oct 4;17(1):346. doi: 10.1186/s12936-018-2495-y.
2
A Suggested Standard Treatment of Malaria Based upon the Results of the Controlled Investigation of over 3,700 Cases.基于对3700多例病例的对照研究结果提出的疟疾标准治疗方案。
Ind Med Gaz. 1930 Nov;65(11):603-620.
3
Geographical variation in Plasmodium vivax relapse.间日疟原虫复发的地理差异。
中国 2014-2021 年输入性疟疾患者延迟就诊和诊断的特征及影响因素:一项回顾性研究
Infect Dis Poverty. 2022 Dec 22;11(1):125. doi: 10.1186/s40249-022-01050-3.
4
Clinical impact of vivax malaria: A collection review.《 vivax 疟疾的临床影响:文献综述》。
PLoS Med. 2022 Jan 18;19(1):e1003890. doi: 10.1371/journal.pmed.1003890. eCollection 2022 Jan.
5
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.采用超敏定量 PCR 评估磷酸萘酚喹对老挝无症状间日疟原虫感染复发的影响:一项随机对照临床试验。
Malar J. 2020 Jan 3;19(1):4. doi: 10.1186/s12936-019-3091-5.
6
Plasmodium vivax severe imported malaria in two migrants in France.两例输入性疟疾病例在法的移民中,疟原虫 vivax 严重感染。
Malar J. 2019 Dec 16;18(1):422. doi: 10.1186/s12936-019-3067-5.
Malar J. 2014 Apr 15;13:144. doi: 10.1186/1475-2875-13-144.
4
Malariotherapy--insanity at the service of malariology.疟原虫疗法——为疟疾学服务的疯狂之举。
Adv Parasitol. 2013;81:223-55. doi: 10.1016/B978-0-12-407826-0.00006-0.
5
Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.对恶性疟原虫的基因分型显示,加尔各答既有短期潜伏期又有长期潜伏期的复发模式。
PLoS One. 2012;7(7):e39645. doi: 10.1371/journal.pone.0039645. Epub 2012 Jul 13.
6
Determinants of relapse periodicity in Plasmodium vivax malaria.影响间日疟复发周期性的因素。
Malar J. 2011 Oct 11;10:297. doi: 10.1186/1475-2875-10-297.
7
Plasmochin toxicity; analysis of 258 cases.扑疟喹毒性;258例分析
Ann Intern Med. 1946 Jul;25:103-12. doi: 10.7326/0003-4819-25-1-103.
8
Experimental Malaria: Recurrence after Nine Months.实验性疟疾:九个月后复发
Br Med J. 1901 Jul 13;2(2115):77. doi: 10.1136/bmj.2.2115.77.
9
Chemotherapeutic suppression and prophylaxis in malaria.疟疾的化疗抑制与预防
Trans R Soc Trop Med Hyg. 1945 May;38(5):311-65.
10
Studies in human malaria; homologous strain superinfection during latency in subjects with sporozoite-induced vivax malaria (St. Elizabeth strain).人类疟疾研究;间日疟原虫(圣伊丽莎白株)诱导的潜伏期中的同源株重复感染。
Am J Hyg. 1947 Jul;46(1):141-8.